JENNA GOLDSTEIN: Open Payments
NPI 1134813249 · SMITHTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,393 in 142 payments from 25 companies in 2025. Trend: 2023 $1,189 · 2024 $3,662 · 2025 $3,393
Food & beverage: $3,348Education: $45
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 13 | $392 |
| Bayer Healthcare Pharmaceuticals Inc. | 27 | $390 |
| Lilly USA, LLC | 10 | $335 |
| BETA BIONICS, INC. | 5 | $282 |
| Novartis Pharmaceuticals Corporation | 13 | $248 |
| Novo Nordisk Inc | 12 | $247 |
| RECORDATI_RARE_DISEASES_INC. | 8 | $184 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $182 |
| Insulet Corporation | 7 | $149 |
| SANOFI-AVENTIS U.S. LLC | 6 | $135 |
Products named: Kerendia, JARDIANCE, iLet Bionic Pancreas, LEQVIO, RECORLEV, ISTURISA, GVOKE HYPOPEN, Omnipod.
Industry payments across NY — which companies pay providers there.
